Section Arrow
RMD.NYSE
- ResMed
Quotes are at least 15-min delayed:2025/09/17 05:54 EDT
Pre Market
Last
 --
-- (--)
Bid
234.81
Ask
433.43
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 272.6
+1.41 (+0.52%)
Day High 
273.7 
Prev. Close
271.19 
1-M High
293.81 
Volume 
840.85K 
Bid
234.81
Ask
433.43
Day Low
270.08 
Open
270.42 
1-M Low
265.49 
Market Cap 
39.71B 
Currency USD 
P/E 28.52 
%Yield 0.8 
10-SMA 273.61 
20-SMA 279.11 
50-SMA 274.3 
52-W High 293.81 
52-W Low 199.92 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
9.51/11.71
Enterprise Value
40.52B
Balance Sheet
Book Value Per Share
40.76
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
5.15B
Operating Revenue Per Share
29.88
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BNGOBionano Genomics Inc1.78-0.99-35.74%0.02PE
Pre Market 1.79 +0.01 +0.56%
HBIOHarvard Bioscience0.4849+0.0454+10.33%-- 
Pre Market 0.463 -0.0219 -4.52%
AVTRAvantor12.71+0.32+2.58%12.27PE
Pre Market 12.71 0 0.00%
BAXBaxter International23.87+0.07+0.29%140.32PE
Pre Market 24 +0.13 +0.54%
MBOTMicrobot Medical3.34-0.08-2.34%-- 
Pre Market 3.39 +0.05 +1.50%
Quotes are at least 15-min delayed:2025/09/17 05:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.